Financial results for Year ended December 31, 2025
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 65900901
- Dividend
- 12
- Unconsolidated Pat
- 10025315
- Bonus
- 0
- Unconsolidated Quarter Eps
- 31.48
- Ex Date
- 2026-04-24
- Right Price
- 0
- Book Closure Dates
- 2026-04-25 - 2026-04-30